Atrial fibrillation prevention: an appraisal of current evidence
- PMID: 29191806
- DOI: 10.1136/heartjnl-2017-311546
Atrial fibrillation prevention: an appraisal of current evidence
Abstract
Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in reducing the risk of AF occurrence (or recurrence). In this review, we briefly summarised the role of the major risk factors associated with the incidence of AF, as well as the effectiveness of interventions aimed at controlling these risk factors. Several general risk factors, such as alcohol consumption, physical activity, smoking habit, as well as specific cardiovascular risk factors as diabetes mellitus, hypertension and obesity have a relevant impact in determining the occurrence of AF, along with a strong clinical evidence of a dose-effect response mechanism for most of the factors examined. Specific interventions aimed at controlling risk factors have been showed to clearly reduce the risk of AF in several cohorts. Even more importantly, integrated programmes aimed at controlling for multiple risk factors would be more efficient in terms of reducing risk of AF, in particular whena stricter control is observed. AF prevention requires a series of initiatives focused on the many risk factors that we reviewed, as well as a more integrated approach, which should involve many stakeholders at different levels. In this light and also considering the constantly changing epidemiology, AF prevention may constitute a future 'win-win' strategy for all the stakeholders.
Keywords: atrial fibrillation; cardiac risk factors and prevention; epidemiology; obesity; stroke.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Lifestyle modification in the prevention and treatment of atrial fibrillation.Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):117-25. doi: 10.1016/j.pcad.2015.07.001. Epub 2015 Jul 13. Prog Cardiovasc Dis. 2015. PMID: 26184674 Review.
-
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.Europace. 2011 Mar;13(3):308-28. doi: 10.1093/europace/eur002. Europace. 2011. PMID: 21345926 Review.
-
Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification.Am J Cardiol. 2021 Dec 1;160:46-52. doi: 10.1016/j.amjcard.2021.08.042. Epub 2021 Sep 25. Am J Cardiol. 2021. PMID: 34583808
-
Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies.Mayo Clin Proc. 2013 Apr;88(4):394-409. doi: 10.1016/j.mayocp.2013.01.022. Mayo Clin Proc. 2013. PMID: 23541013 Review.
-
Atrial fibrillation: A review of modifiable risk factors and preventive strategies.Rom J Intern Med. 2019 Jun 1;57(2):99-109. doi: 10.2478/rjim-2018-0045. Rom J Intern Med. 2019. PMID: 30648669 Review.
Cited by
-
Hybrid Endo-Epicardial Therapies for Advanced Atrial Fibrillation.J Clin Med. 2024 Jan 24;13(3):679. doi: 10.3390/jcm13030679. J Clin Med. 2024. PMID: 38337373 Free PMC article. Review.
-
The evolving epidemiological landscape of atrial fibrillation: trends, challenges, and opportunities for improved patient care.Europace. 2025 Feb 5;27(2):euaf026. doi: 10.1093/europace/euaf026. Europace. 2025. PMID: 40036692 Free PMC article. No abstract available.
-
Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.BMC Cardiovasc Disord. 2021 Mar 12;21(1):134. doi: 10.1186/s12872-021-01942-6. BMC Cardiovasc Disord. 2021. PMID: 33711943 Free PMC article.
-
Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis.Ann Thorac Cardiovasc Surg. 2022 Feb 20;28(1):18-31. doi: 10.5761/atcs.ra.21-00126. Epub 2021 Aug 20. Ann Thorac Cardiovasc Surg. 2022. PMID: 34421096 Free PMC article.
-
Obesity and Atrial Fibrillation: A Comprehensive Review.Methodist Debakey Cardiovasc J. 2025 Feb 18;21(2):35-43. doi: 10.14797/mdcvj.1516. eCollection 2025. Methodist Debakey Cardiovasc J. 2025. PMID: 39990752 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous